SHR-1316 (adebrelimab)

adebrelimab · Shanghai Pulmonary Hospital (sponsor) / unspecified

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-1316 (adebrelimab), covering 2023-05-17 to 2023-05-17. Get the full timeline:

Most recent: Clinical Trial Update: The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer [Phase 3]

See pricing